Literature DB >> 7633763

Efficacy of flashlamp-pumped pulsed dye laser therapy for port wine stains: clinical assessment and histopathological characteristics.

K Onizuka1, K Tsuneda, Y Shibata, M Ito, I Sekine.   

Abstract

Clinicopathological evaluation of flashlamp-pumped dye laser therapy for port wine stains was conducted on 474 subjects (135 male and 339 female) ranging in age from less than a year to 85 years (median = 17; lower quartile = 7 and upper quartile = 28). There was a significant variation in the rate of favourable response among lesion sites but the variation in relation to sex, age and radiation dose was not significant. Histological investigations of skin biopsy specimens from 23 subjects indicated that the mean depth of vessels is the main prognostic factor. The critical value (standard error) of the mean depth for a favourable response was estimated as 930(50) microns. Applications of this estimate to clinical prognosis are discussed.

Mesh:

Year:  1995        PMID: 7633763     DOI: 10.1016/0007-1226(95)90064-0

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  4 in total

1.  Recent developments in lasers and the treatment of birthmarks.

Authors:  M Waner
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

Review 2.  An overview of clinical and experimental treatment modalities for port wine stains.

Authors:  Jennifer K Chen; Pedram Ghasri; Guillermo Aguilar; Anne Margreet van Drooge; Albert Wolkerstorfer; Kristen M Kelly; Michal Heger
Journal:  J Am Acad Dermatol       Date:  2012-02-03       Impact factor: 11.527

3.  Use of reflectance spectrophotometry to predict the response of port wine stains to pulsed dye laser.

Authors:  Shlomit Halachmi; Ron Azaria; Roy Inbar; Dean Ad-El; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-04-23       Impact factor: 3.161

4.  Utility of Dermoscopy before and after Laser Irradiation in Port Wine Stains.

Authors:  Makiko Shirakawa; Toshiyuki Ozawa; Satoki Wakami; Masamitsu Ishii; Teruichi Harada
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.